We then assessed apoptosis by cleaved-caspase-3 (CC3) staining and found that apoptosis rates were low and only slightly increased in α6KO/Brca1p53-KO tumors (around 2–3% of CC3 + tumor cells; Fig. 2B). The gene discussed is CASP3; the disease is neoplasm.